CBS News
@CBSNews·7M subscribers·153.5K videos
New treatment to slow progression of early Alzheimer's approved by FDA
Posted
July 3, 2024
Views
2,927
Likes
67
Comments
11
Engagement
2.66%
July 3, 2024
2,927
67
11
2.66%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:46Now PlayingThe FDA approved a new Alzheimer's treatment called donanemab on Tuesday. It is designed to help patients in the early stages of the disease. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube
Watch CBS News 24/7
Download the CBS News app
Follow "CBS Mornings" on Instagram
Like "CBS Mornings" on Facebook
Follow "CBS Mornings" on X
Subscribe to our newsletter
Try Paramount+ free
For video licensing inquiries, contact: licensing@veritone.com
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
